Cartesian Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:RNAC) | MetaTrader

전체 차트 열기 Full chart

뉴스

Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)

Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates

Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIG, Cartesian Therapeutics에 ’매수’ 의견 재확인

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

미즈호, Cartesian Therapeutics 투자의견 ’아웃퍼폼’ 유지

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares